
Gufic BioSciences Ltd Stock Falls to 52-Week Low Amidst Continued Downtrend
2026-01-28 16:01:22Shares of Gufic BioSciences Ltd have declined to within 4.84% of their 52-week low, marking a significant downturn for the pharmaceutical and biotechnology company. The stock closed near Rs 285, reflecting a sustained period of depreciation amid broader market gains.
Read full news article
Gufic BioSciences Ltd is Rated Strong Sell
2026-01-21 10:10:53Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 21 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Gufic BioSciences Ltd is Rated Strong Sell
2026-01-10 10:10:49Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 10 January 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Gufic BioSciences Ltd Faces Intensified Downtrend Amid Technical Weakness
2026-01-09 08:02:11Gufic BioSciences Ltd has experienced a notable shift in price momentum, with technical indicators signalling a bearish trend across multiple timeframes. The company’s shares have declined by 2.88% today, reflecting growing investor caution amid deteriorating technical signals and a downgrade in its Mojo Grade to Strong Sell.
Read full news article
Gufic BioSciences Ltd Faces Bearish Momentum Amid Technical Indicator Shifts
2026-01-05 08:02:04Gufic BioSciences Ltd, a key player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its technical momentum, with several indicators signalling a bearish trend. Despite a modest weekly price gain, the stock’s overall technical profile has deteriorated, prompting a downgrade to a Strong Sell rating by MarketsMOJO as of 17 Nov 2025.
Read full news article
Gufic BioSciences Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-01-01 08:01:45Gufic BioSciences Ltd has experienced a notable shift in its technical momentum, reflecting a complex interplay of mildly bearish and bullish signals across key indicators. Despite a modest daily price increase of 0.93%, the stock remains under pressure with a Strong Sell mojo grade, underscoring ongoing challenges in the Pharmaceuticals & Biotechnology sector.
Read full news article
Gufic BioSciences Ltd Faces Bearish Momentum Amid Technical Downturn
2025-12-31 08:03:05Gufic BioSciences Ltd has experienced a marked deterioration in its technical outlook, with key momentum indicators signalling a shift towards bearishness. The stock’s recent price action, combined with weakening moving averages and mixed momentum oscillators, underscores mounting challenges for investors amid a broader sectoral and market context.
Read full news article
Gufic BioSciences Ltd is Rated Strong Sell
2025-12-30 10:10:31Gufic BioSciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 December 2025, providing investors with the latest insights into its performance and outlook.
Read full news article
Gufic BioSciences Faces Bearish Momentum Amid Technical Indicator Shifts
2025-12-29 08:01:44Gufic BioSciences, a player in the Pharmaceuticals & Biotechnology sector, is currently exhibiting a shift in price momentum as reflected by recent technical indicator changes. The stock’s performance over various time frames contrasts notably with benchmark indices, while key technical signals suggest a prevailing bearish trend in the near term.
Read full news articleGufic Biosciences Limited - Updates
03-Dec-2019 | Source : NSEGufic Biosciences Limited has informed the Exchange regarding 'grant of patent'.
Gufic Biosciences Limited - Board meeting Cancelled
15-Nov-2019 | Source : NSEGufic Biosciences Limited has informed the Exchange regarding Seeking extension of time for approval of Standalone Financial Results for the quarter and half year ended September 30, 2019.
Gufic Biosciences Limited - Trading Window
08-Nov-2019 | Source : NSEGufic Biosciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Corporate Actions
No Upcoming Board Meetings
Gufic BioSciences Ltd has declared 10% dividend, ex-date: 22 Sep 25
No Splits history available
No Bonus history available
No Rights history available






